Executive Summary
Experts recommend stopping Ozempic before most surgeries 11 Feb 2025—Experts recommend stopping Ozempic before most surgeries. Here's what to know about taking Ozempic before surgery.
The increasing popularity of semaglutide, a GLP-1 receptor agonist used for managing type 2 diabetes mellitus and promoting weight loss, has brought to light important considerations for patients planning to undergo surgery. While semaglutide offers significant benefits for many, its impact on gastric emptying can introduce specific risks during anesthesia and surgical procedures. Understanding these risks and adhering to recommended guidelines is crucial for patient safety.
One of the primary concerns associated with semaglutide and having surgery is its effect on gastric motility. Semaglutide medications, including well-known brands like Ozempic, Wegovy, and Trulicity, are known to significantly delay stomach emptying. This means that even after adhering to standard fasting (eating) instructions before surgery, patients may still have a higher-than-normal volume of undigested food in their stomach. This residual gastric content poses a substantial risk of pulmonary aspiration of gastric contents during anesthesia. Aspiration occurs when stomach contents are inhaled into the lungs, which can lead to serious complications such as pneumonia and acute respiratory distress. This is why withholding the medication before elective surgery is a common recommendation.
The American Society of Anesthesiologists (ASA) has issued guidance suggesting that patients on GLP-1 agonists should consider discontinuing semaglutide two weeks before surgery. This recommendation is based on studies and clinical observations highlighting the potential for increased residual gastric volume. Some experts even recommend stopping Ozempic injections at least 7 days (1 week) before elective surgical procedures, while others advise a longer period of two weeks prior to your surgical date. The rationale behind these recommendations is to allow the medication's effects on gastric emptying to diminish, thereby reducing the risk of aspiration. The phrase "Why You Must Stop Semaglutide Before Surgery" encapsulates this critical safety concern.
However, the medical community is actively researching and debating the optimal perioperative management of patients taking semaglutide. While the risk of aspiration is a significant concern, some recent studies suggest that the risk may be lower than previously thought, or that semaglutide was not associated with postoperative pneumonia in certain patient groups. For instance, one study indicated "no cases of aspiration or respiratory compromise" in patients who continued semaglutide at the time of their surgical procedure. This emerging research suggests that for some patients, continuing semaglutide might be a viable option, potentially leading to fewer hyperglycemic episodes and improved glycemic control, which can be beneficial for wound healing.
The decision of whether to stop semaglutide before surgery is complex and depends on several factors, including the type of surgery, the patient's individual health status, and the specific recommendations of their healthcare team. For patients with type 2 diabetes mellitus, omitting semaglutide could lead to an increased risk of post-operative infection and delayed wound healing due to poor glycaemic control if omitted. Therefore, a careful balance must be struck.
It is imperative for patients to have an open and thorough discussion with their surgeon and anesthesiologist about their semaglutide use well in advance of their scheduled surgery. Patients should continue to take GLP-1 medication before and after surgery only if explicitly advised by their medical team. The advice to stop 7 days before surgery for weekly injections is a common guideline, but individual circumstances may necessitate different approaches.
Ultimately, the goal is to ensure patient safety by mitigating potential risks associated with semaglutide and surgery. While some experts recommend stopping Ozempic before most surgeries, the evolving research landscape means that guidelines may continue to be refined. Patients should always follow the specific instructions provided by their healthcare providers regarding medication management before, during, and after their surgical procedures. Understanding that GLP-1 agonist drugs for diabetes or weight loss may increase risks in surgery and that these medications can be problematic when a person undergoes anesthesia is the first step in ensuring a safe surgical experience.
Related Articles
Frequently Asked Questions
Here are the most common questions about .
Leave a Comment
Share your thoughts, feedback, or additional insights on this topic.
